Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 20 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

45%

9 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
6(46.2%)
Phase 3
3(23.1%)
N/A
2(15.4%)
Early Phase 1
1(7.7%)
Phase 2
1(7.7%)
13Total
Phase 4(6)
Phase 3(3)
N/A(2)
Early Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT07129499Not ApplicableNot Yet Recruiting

Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas

Role: lead

NCT07123116Not ApplicableNot Yet Recruiting

Shenbai Granules for Preventing Recurrence of Low-Risk Colorectal Adenomas

Role: lead

NCT05709249Phase 3Recruiting

Xian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer

Role: lead

NCT06613373Phase 4Not Yet Recruiting

An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer

Role: lead

NCT06537674Not Yet Recruiting

Pyrotinib Combined With Trastuzumab Subcutaneously Compared Intravenous Administration in the Treatment of HER2-positive Early Breast Cancer

Role: lead

NCT06136026Not Yet Recruiting

Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer

Role: lead

NCT03616444Phase 2Completed

A Randomized Clinical Trial of Shenbai Granules in Reducing Recurrence of Colorectal Adenoma

Role: lead

NCT05305456Phase 3Completed

Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19

Role: lead

NCT05482009Completed

Treatment of Angina Pectoris After Coronary Revascularization With Integrated Traditional Chinese and Western Medicine

Role: lead

NCT04812236Phase 4Unknown

Clinical Study on Wuling Powder in Treating Metabolic Syndrome of Spleen Deficiency and Dampness

Role: lead

NCT04509323Phase 4Unknown

Clinical Study of Huperzine A in the Treatment of Patients With Hypertensive Cerebral Hemorrhage

Role: lead

NCT04306497Completed

TCM Differentiation and Treatment Protocol of COVID-19

Role: lead

NCT04261920Phase 4Unknown

Clinical Trial Scheme of Huangqi Guizhi Wuwu Decoction

Role: lead

NCT03943420Unknown

One Research on Improving Cognitive Impairment Caused by Hypertension

Role: lead

NCT03745261Phase 3Unknown

Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

Role: collaborator

NCT03264794Phase 4Unknown

the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)

Role: lead

NCT03016832Early Phase 1Unknown

Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney Disease

Role: lead

NCT03020901Unknown

the Clinical Trial of Teicoplanin for Injection

Role: lead

NCT03020940Unknown

The Clinical Trial of Cefuroxime Axetil Dispersible Tablets

Role: lead

NCT02993419Phase 4Unknown

Bacillus Particles Prevent Children Antibiotics Associated Diarrhea

Role: lead

All 20 trials loaded